Indacaterol did not show non-inferiority in terms of annualised exacerbation rates : 0.79 ( indacaterol , n = 1529 ) versus 0.61 ( tiotropium , n = 1543 ) ; ratio 1.29 ( one-sided 97.5 % CI upper limit 1.44 ) .